NEW YORK (360Dx) – Vortex Biosciences said today that it has entered a collaboration with BioView to develop an integrated workflow for identifying clinical biomarkers on circulating tumor cells.

Financial and additional terms of the collaboration were not disclosed.

The firms said that they are integrating their technologies to create a workflow for the isolation and characterization of CTCs that provides clinical insights to physicians.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.